Dr. Gubatan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Dr. John Mark Gubatan is a gastroenterologist based in Stanford, CA, specializing in inflammatory bowel disease. He completed his gastroenterology fellowship at Stanford Health Care and his internal medicine residency at Beth Israel Deaconess Medical Center, following his medical degree from Harvard Medical School. Dr. Gubatan is employed at Stanford Health Care and has contributed several publications on inflammatory bowel disease topics, including the immunogenicity of therapeutic antibodies and vitamin D's influence in ulcerative colitis. He has served as the principal investigator in clinical trials focused on vitamin D regulation in gut-specific B cells. Dr. Gubatan's accolades include the Doris Duke Physician Scientist Fellowship Award, among others.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Gastroenterology, 2018 - 2021
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2014 - 2017
- Harvard Medical SchoolClass of 2014
Certifications & Licensure
- CA State Medical License 2018 - 2025
- MA State Medical License 2017 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Doris Duke Physician Scientist Fellowship Award Doris Duke Charitable Foundation (DDCF), 2021-2023
- Chan Zuckerberg Biohub Physician Scientist Scholar Award Chan Zuckerberg Biohub, 2020-2022
- Clinical Research Loan Repayment Program Award National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 2020-2022
- Join now to see all
Clinical Trials
- Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease Start of enrollment: 2021 Jul 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- A Similar Mutation in the AAUU-Rich Elements of the Mouse TNF Gene Results in a Distinct Ileocolitic Phenotype: A New Strain of TNF-Overexpressing Mice.Amruth Chilukuri, Margaret Kim, Taniya Mitra, John M Gubatan, Josef Urrete
Inflammatory Bowel Diseases. 2025-01-04 - Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations.Ole Haagen Nielsen, Alexander Hammerhøj, Mark Andrew Ainsworth, John Gubatan, Geert D'Haens
Drugs. 2025-01-01 - 1 citationsImmune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma.Gliceida Galarza Fortuna, Rahul Banerjee, Constanza Savid-Frontera, Jinming Song, Carlos M Morán-Segura
Blood Cancer Journal. 2024-10-16
Press Mentions
- Getting More Vitamin D May Help Ward off Ulcerative Colitis Flare-UpsApril 5th, 2017
- Vitamin D May Be More Important Than Known for Ulcerative ColitisFebruary 20th, 2017
- Low Vitamin D Levels Linked to Relapse of Ulcerative ColitisFebruary 17th, 2017
- Join now to see all
Professional Memberships
- Member
- Member
- European Crohns and Colitis OrganisationMember
- American Society for Gastrointestinal EndoscopyMember
Other Languages
- French, Spanish, Tagalog
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: